Allied Biotech Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 676.76 million compared to TWD 618.07 million a year ago. Net income was TWD 13.04 million compared to TWD 79.47 million a year ago.

Basic earnings per share from continuing operations was TWD 0.14 compared to TWD 0.84 a year ago. Diluted earnings per share from continuing operations was TWD 0.14 compared to TWD 0.83 a year ago.